Cetrorelix recalls

The FDA has published 3 recalls involving Cetrorelix since 2020. The latest was reported on 18 Feb 2026. Most were for foreign material. Akorn has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls3since 2020

Last 12 months1reported

Class I00% of total

Ongoing2latest 18 Feb 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 1Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 3 100%Class III 0 0%

Why cetrorelix is recalled

Companies

By year

2026133%
2023133%
2020133%

Ongoing cetrorelix recalls

2 active

Reported	Class	Recall	Company	Reason	Where
18 Feb 2026Drug	CLASS II	Cetrorelix Acetate for Injection , 0.25 mg per vial, Single-Dose Kit recalled	Meitheal Pharmaceuticals	Other	Nationwide
7 Jun 2023Drug	CLASS II	Cetrorelix Acetate for Injection, 0.25 mg recalled by Akorn	Akorn	Potency & Assay	Nationwide

All cetrorelix recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
18 Feb 2026Drug	CLASS II	Cetrorelix Acetate for Injection , 0.25 mg per vial, Single-Dose Kit recalled	Meitheal Pharmaceuticals	Other	Nationwide
7 Jun 2023Drug	CLASS II	Cetrorelix Acetate for Injection, 0.25 mg recalled by Akorn	Akorn	Potency & Assay	Nationwide
15 Jul 2020Drug	CLASS II	Cetrotide (cetrorelix acetate for Injection) 0.25 mg recalledCetrotide	EMD Serono	Foreign Material	Nationwide

Should you stop taking Cetrorelix?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.